BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1462087)

  • 1. [Breast cancer: a practitioner's viewpoint].
    Prahin JJ
    Rev Med Suisse Romande; 1992 Nov; 112(11):963. PubMed ID: 1462087
    [No Abstract]   [Full Text] [Related]  

  • 2. [Breast cancer from the general practitioner's viewpoint].
    Toussaint D
    Rev Med Brux; 1995; 16(4):210. PubMed ID: 7481224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [After care from the psychotherapeutic viewpoint. Model proposal in breast cancer].
    Perez-Gay BM
    Schwest Rev; 1979 Feb; 17(2):10. PubMed ID: 254315
    [No Abstract]   [Full Text] [Related]  

  • 4. Women's psychological reactions to breast cancer.
    Payne DK; Sullivan MD; Massie MJ
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):89-97. PubMed ID: 8614852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The general practitioner's contribution to the treatment and care of oncologic patients--meaningful possibilities from a preventive viewpoint].
    van der Linde F
    Med Welt; 1979 Oct; 30(41):1509-14. PubMed ID: 514030
    [No Abstract]   [Full Text] [Related]  

  • 6. Health care costs for treatment of disseminated breast cancer.
    Dahlberg L; Lundkvist J; Lindman H
    Eur J Cancer; 2009 Jul; 45(11):1987-91. PubMed ID: 19398326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viewpoint: the cancer patient.
    Kaplan M
    Cancer Nurs; 1983 Apr; 6(2):103-7. PubMed ID: 6550518
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM; Shim B; Goodman S; Amonkar MM
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic burden of breast cancer in California.
    Max W; Sung HY; Stark B
    Breast Cancer Res Treat; 2009 Jul; 116(1):201-7. PubMed ID: 18683041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of metastatic breast cancer: are we prepared to cope with our own success?
    Jimeno A; Cortés-Funes H; Colomer R
    Br J Cancer; 2004 Dec; 91(12):2101; author reply 2102. PubMed ID: 15599385
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of advanced nursing care on quality of life and cost outcomes of women diagnosed with breast cancer.
    Ritz LJ; Nissen MJ; Swenson KK; Farrell JB; Sperduto PW; Sladek ML; Lally RM; Schroeder LM
    Oncol Nurs Forum; 2000 Jul; 27(6):923-32. PubMed ID: 10920832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age differences in the psychosocial problems encountered by breast cancer patients.
    Mor V; Malin M; Allen S
    J Natl Cancer Inst Monogr; 1994; (16):191-7. PubMed ID: 7999464
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of cancer economics. Based on a presentation by C. Daniel Mullins, PhD.
    Am J Manag Care; 1999 Jun; 5(6 Suppl):S371-6. PubMed ID: 10538848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stopping the drain of dollars spent on breast cancer.
    Kneece J
    Adm Radiol; 1994 Jun; 13(6):27-9. PubMed ID: 10136526
    [No Abstract]   [Full Text] [Related]  

  • 16. Conceptualization and sources of costs from breast cancer: findings from patient and caregiver focus groups.
    Lauzier S; Maunsell E; De Koninck M; Drolet M; Hébert-Croteau N; Robert J
    Psychooncology; 2005 May; 14(5):351-60. PubMed ID: 15386763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The financial burden of cancer: estimates from a study of insured women with breast cancer.
    Arozullah AM; Calhoun EA; Wolf M; Finley DK; Fitzner KA; Heckinger EA; Gorby NS; Schumock GT; Bennett CL
    J Support Oncol; 2004; 2(3):271-8. PubMed ID: 15328826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant anthracyclines and taxanes: quantifying the costs of therapeutic advances in breast cancer.
    Morris PG; Bach PB
    Onkologie; 2009 Sep; 32(8-9):464-6. PubMed ID: 19745589
    [No Abstract]   [Full Text] [Related]  

  • 19. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia.
    Groot MT; Baltussen R; Uyl-de Groot CA; Anderson BO; Hortobágyi GN
    Breast J; 2006; 12 Suppl 1():S81-90. PubMed ID: 16430401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial of no wound drains and early discharge in the treatment of women with breast cancer.
    Purushotham AD; McLatchie E; Young D; George WD; Stallard S; Doughty J; Brown DC; Farish C; Walker A; Millar K; Murray G
    Br J Surg; 2002 Mar; 89(3):286-92. PubMed ID: 11872051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.